Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancer
Open Access
- 31 July 1997
- Vol. 50 (1) , 73-78
- https://doi.org/10.1016/s0090-4295(97)00202-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Prostate Specific Antigen Density is not an Independent Predictor of Response for Prostate Cancer Treated by Conformal RadiotherapyJournal of Urology, 1995
- The treatment of prostate cancer by conventional radiation therapy: An analysis of long-term outcomeInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Prostate-specific antigen and radiation therapy for clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implicationsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Predictive value of prostate-specific antigen density for the presence of micrometastatic carcinoma of the prostateUrology, 1994
- Prostate-specific antigen density: A new prognostic indicator for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Determination of prostate volume with transrectal US for cancer screening. Part I. Comparison with prostate-specific antigen assays.Radiology, 1991
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958